Your browser doesn't support javascript.
loading
ADAM-17: a novel therapeutic target for triple negative breast cancer.
McGowan, P M; Mullooly, M; Caiazza, F; Sukor, S; Madden, S F; Maguire, A A; Pierce, A; McDermott, E W; Crown, J; O'Donovan, N; Duffy, M J.
Afiliação
  • McGowan PM; Department of Pathology and Laboratory Medicine, St Vincent's University Hospital, Dublin; UCD School of Medicine and Medical Science, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin.
  • Mullooly M; Department of Pathology and Laboratory Medicine, St Vincent's University Hospital, Dublin; UCD School of Medicine and Medical Science, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin.
  • Caiazza F; Department of Pathology and Laboratory Medicine, St Vincent's University Hospital, Dublin; UCD School of Medicine and Medical Science, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin.
  • Sukor S; UCD School of Medicine and Medical Science, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin; Department of Medical Oncology, St Vincent's University Hospital, Dublin.
  • Madden SF; National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.
  • Maguire AA; Department of Pathology and Laboratory Medicine, St Vincent's University Hospital, Dublin; UCD School of Medicine and Medical Science, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin.
  • Pierce A; Department of Pathology and Laboratory Medicine, St Vincent's University Hospital, Dublin; UCD School of Medicine and Medical Science, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin.
  • McDermott EW; UCD School of Medicine and Medical Science, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin.
  • Crown J; Department of Medical Oncology, St Vincent's University Hospital, Dublin.
  • O'Donovan N; National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.
  • Duffy MJ; Department of Pathology and Laboratory Medicine, St Vincent's University Hospital, Dublin; UCD School of Medicine and Medical Science, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin. Electronic address: patricia.mcgowan@ucd.ie.
Ann Oncol ; 24(2): 362-369, 2013 Feb.
Article em En | MEDLINE | ID: mdl-22967992
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Proteínas ADAM / Receptores ErbB Idioma: En Ano de publicação: 2013 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Proteínas ADAM / Receptores ErbB Idioma: En Ano de publicação: 2013 Tipo de documento: Article